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Problem
Sterile intra-amniotic inflammation is associated with spontaneous pre-
term labor. Alarmins are proposed to mediate this inflammatory process.
The aim of this study was to determine whether intra-amniotic adminis-
tration of an alarmin, HMGB1, could induce preterm labor/birth.
Method of Study
Pregnant B6 mice were intra-amniotically or intraperitoneally injected
with HMGB1 or PBS (control). Following injection, the gestational age
and the rates of preterm birth and pup mortality were recorded.
Results
Intra-amniotic injection of HMGB1 led to preterm labor/birth [HMGB1
57% (4/7) versus PBS 0% (0/6); P = 0.049) and a high rate of pup mor-
tality at week 1 [HMGB1 60.9  11.7% (25/41) versus PBS
28.9  12.6% (11/38); P = 0.001). Intraperitoneal injection of HMGB1
did not induce preterm labor/birth.
Conclusion
Intra-amniotic administration of HMGB1 induces preterm labor/birth.
Introduction
Preterm birth, or birth occurring prior to 37 weeks of
gestation, is the leading cause of perinatal morbidity
and mortality. Approximately 70% of all preterm
births are preceded by spontaneous preterm labor,1 a
syndrome caused by multiple pathological processes.2
Of all the putative causes associated with sponta-
neous preterm labor, only intra-amniotic inflamma-
tion/infection has been causally linked to preterm
birth.2 Sterile intra-amniotic inflammation, an
inflammatory process [interleukin (IL) 6 ≥ 2.6 ng/
mL] occurring in the absence of microorganisms, is
more common than microbial-associated intra-
amniotic inflammation in patients with preterm labor
and intact fetal membranes.3 Sterile intra-amniotic
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inflammation is also frequently observed in patients
with a sonographic short cervix4 and in those with
preterm prelabor rupture of the membranes and clin-
ical chorioamnionitis.5 The inflammatory process in
sterile inflammation results from activation of the
innate immune system by endogenous danger
signals, derived from necrosis or cellular stress,6 ter-
med damage-associated molecular pattern molecules
(DAMPs),7 or alarmins.8 As the concentration of sev-
eral alarmins, including IL1a,9 S100 calcium-binding
protein B,10 heat-shock protein 70,11 and high-mobi-
lity group box-1 (HMGB1),12,13 is increased in the
amniotic fluid of women with intra-amniotic inflam-
mation, we proposed that these danger signals are
responsible for sterile inflammation.11–13
HMGB1 is an evolutionarily conserved protein that
stabilizes nucleosome formation and facilitates gene
transcription while localized to the nucleus; however,
it acts as an alarmin when released extracellularly.14
HMGB1 demonstrates the four classic characteristics
of an alarmin: (i) rapid release following non-pro-
grammed cell death (i.e., necrosis) but not as a result
of apoptosis; (ii) production and release by viable
immune cells through specialized secretion systems or
the endoplasmic reticulum–Golgi secretion pathway;
(iii) recruitment and activation of innate immune
cells via pattern recognition receptors (PRR) which, in
turn, can directly or indirectly promote adaptive
immune responses; and (iv) restoration of homeosta-
sis through the healing of tissue directly or indirectly
damaged by inflammation.15
HMGB1 concentration in the maternal serum is
elevated in pregnancies with reduced fetal move-
ment but is not associated with preterm labor/
birth.16 Therefore, we hypothesized that intra-
amniotic, but not systemic, administration of
HMGB1 would induce preterm birth. We tested this
hypothesis by injecting pregnant B6 mice with
HMGB1 intra-amniotically or intraperitoneally.
Materials and methods
Animals
C57BL/6 (B6) mice were purchased from The Jackson
Laboratory in Bar Harbor, ME, USA, and bred in the
animal care facility at the C.S. Mott Center for Human
Growth and Development at Wayne State University,
Detroit, MI, USA. All mice were kept under a
circadian cycle (light:dark = 12:12 hr). Females, 8–
12 weeks old, were mated with males of the same
phenotype. Female mice were checked daily between
8:00 a.m. and 9:00 a.m. for the appearance of a vagi-
nal plug, which indicated 0.5 days post coitum (dpc).
Females were then housed separately from the males,
their weight was monitored, and a gain of two or more
grams by 12.5 dpc confirmed pregnancy. All proce-
dures were approved by the Institutional Animal Care
and Use Committee (IACUC) at Wayne State Univer-
sity (Protocol Nos. A 09-08-12 and A 07-03-15).
Intra-Amniotic Administration of HMGB1
Pregnant B6 mice were anesthetized on 14.5 dpc by
inhalation of 2–3% isoflurane (Aerrane; Baxter
Healthcare Corporation, Deerfield, IL, USA) and 1–2 L/
min of oxygen in an induction chamber. Anesthesia
was maintained with a mixture of 1.5–2% isoflurane
and 1.5–2 L/min of oxygen. Mice, positioned on a
heating pad, were stabilized with adhesive tape. Fur
removal from the abdomen and thorax was achieved
by applying Nair cream (Church & Dwight Co., Inc.,
Ewing, NJ, USA) to the area. Body temperature was
maintained in the range of 37  1°C and detected with
a rectal probe. Respiratory and heart rates were moni-
tored by electrodes embedded in the heating pad. An
ultrasound probe (VisualSonics Inc., Toronto, ON,
Canada) was fixed and mobilized with a mechanical
holder, and the transducer was slowly moved toward
the abdomen. Ultrasound-guided intra-amniotic injec-
tion of endotoxin-free HMGB1 (IBL International
Corp., Toronto, ON, Canada) at a concentration of
9 ng dissolved in 100 lL of sterile 19 phosphate-buf-
fered saline (PBS; Fisher Scientific Bioreagents, Fair
Lawn, NJ, USA; n = 7) was performed in each amniotic
sac using a 30 G 9 ½ in (0.3 mm 9 25 mm) needle
(BD PrecisionGlide Needle; Becton Dickinson, Franklin
Lakes, NJ, USA) (Fig. 1a). Controls (n = 6) were
injected with 100 lL of PBS alone. The syringe was sta-
bilized by a mechanical holder (VisualSonics Inc). Fol-
lowing ultrasound, mice were placed under a heat
lamp for recovery, which occurred 10–20 min after
heating. On the evening of 17.5 dpc, mice were moni-
tored via video recording using an infrared camera
(Sony Corporation, Tokyo, Japan) in order to deter-
mine gestational age and the rates of preterm birth and
of pup mortality at birth and week 1.
Intraperitoneal Administration of HMGB1
Pregnant B6 mice were intraperitoneally injected
with endotoxin-free HMGB1 on 16.5 dpc (Fig. 2a).
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The concentration of HMGB1 in serum in cases of
reduced fetal movement ranges from 10 ng/mL to
50 ng/mL.16 However, these concentrations are not
associated with spontaneous preterm labor.16 The
in vivo effects of HMGB1 are observed only when a
greater amount (10–100 lg per mouse) is intraperi-
toneally injected.17 Therefore, two different doses
were tested: 20 lg (n = 4) and 50 lg (n = 10) dis-
solved in 200 lL of PBS. Control mice were injected
with 200 lL of PBS (n = 10). Following injection,
mice were monitored via video recording using an
infrared camera in order to determine gestational
age and the rates of preterm birth and of pup mor-
tality at birth and week 1.
Outcome Variables
Gestational age was defined as the time elapsed
from the detection of the vaginal plug (0.5 dpc)
through the delivery of the first pup. The rate of
pup mortality at birth was defined as the percent-
age of pups found dead among the total litter size.
Preterm labor/birth was defined as a delivery occur-
ring before or on 18.5 dpc, and its rate was repre-
sented by the percentage of females delivering
preterm among those delivering at term (19.5  0.5
dpc). The rate of pup mortality at week 1 was
defined as the number of pups that died before
1 week of age among the total number of pups
born alive.
Statistical Analysis
Statistical analyses were performed using SPSS, ver-
sion 19.0 (IBM Corporation, Armonk, NY, USA).
The following tests were performed to compare
differences between the groups: the Mann–Whitney
U-test for gestational age, a t-test for pup weight,
Fisher’s exact test for the rates of preterm labor/
birth, and a logistic regression model for the rates

































































































Fig. 1 Intra-amniotic injection of HMGB1. (a) On 14.5 dpc, pregnant mice were intra-amniotically injected with HMGB1 (9 ng/100 lL; n = 7) or PBS
(100 lL; n = 6), using ultrasound, and mice were video-monitored until delivery. (b) Rate of preterm labor/birth. (c) Gestational age. (d) Rate of
pup mortality at birth. (e) Rate of pup mortality at week 1. (f) Pup weight.
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Results
The frequency of preterm labor/birth was higher
after an intra-amniotic injection of HMGB1 (9 ng/
100 lL) than following an intra-amniotic injection
of PBS [HMGB1 57% (4/7) versus PBS 0% (0/6);
P = 0.049; Fig. 1b]. Pregnant mice injected with
HMGB1 had a shorter gestational age than mice
injected with PBS (HMGB1 18.7  0.3 dpc versus
PBS 19.45  0.3 dpc; P = 0.001; Fig. 1c). Intra-
amniotic injection of HMGB1 was associated with a
modest increase in pup mortality at birth, but this
did not reach statistical significance [HMGB1
14.5  9.3% (7/48) versus PBS 9.5  8.4% (4/42);
Fig. 1d]. In addition, intra-amniotic injection of
HMGB1 was associated with an increased rate of
pup death by the age of 1 week [HMGB1
60.9  11.7% (25/41) versus PBS 28.9  12.6%
(11/38); P = 0.001; Fig. 1e]. No differences in pup
weight were observed between the groups (Fig. 1f).
Intraperitoneal injection of HMGB1 [20 lg/200 lL
(data not shown) or 50 lg/200 lL] did not induce
preterm labor/birth [HMGB1 0% (0/10) versus PBS
0% (0/10); Fig. 2b], and all injected mice delivered at
term (Fig. 2b,c). Intraperitoneal injection of HMGB1
had no effect on pup viability at birth (Fig. 2d). How-
ever, intraperitoneal injection of HMGB1 increased
the rate of pup mortality at week 1 [HMGB1
32.4  9.4% (23/71) versus PBS 13  7.4% (9/69);
P = 0.01; Fig. 2e]. No differences in pup weight were
observed between the groups (Fig. 2f).
Discussion
The etiology of sterile intra-amniotic inflammation is
unknown; yet, this clinical condition has been asso-
ciated with an elevated concentration of HMGB1 in
the amniotic fluid.3 Herein, we demonstrated that
intra-amniotic injection of HMGB1 induces preterm
birth, whereas intraperitoneal injection at a much
higher concentration (an increase of ~300- or 790-
fold per mouse) failed to produce the same effect.
The effect of HMGB1 is likely mediated through
action in the amnion, as HMGB1 is strongly
P = 0.01




























































































Fig. 2 Intraperitoneal injection of HMGB1. (a) On 16.5 dpc, pregnant mice were intraperitoneally injected with HMGB1 (50 lg/200 lL; n = 10) or
PBS (200 lL; n = 10) and video-monitored until delivery. (b) Rate of preterm labor/birth. (c) Gestational age. (d) Rate of pup mortality at birth. (e)
Rate of pup mortality at week 1. (f) Pup weight.
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immunolocalized in the amnion epithelial cells but
weakly present in the chorioamniotic connective tis-
sue layer and infiltrating leukocytes.12
The finding herein provides evidence that an
alarmin – HMGB1 – can induce premature labor
and, therefore, may be involved in signaling parturi-
tion in the context of sterile intra-amniotic inflam-
mation. Further research is needed in order to
investigate the mechanisms whereby HMGB1 in the
amniotic cavity induces spontaneous preterm labor.
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